# Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD

> **NCT07014631** · PHASE2 · COMPLETED · sponsor: **Shenyang Sunshine Pharmaceutical Co., LTD.** · enrollment: 86 (actual)

## Conditions studied

- Anemia in Pre-Dialysis Patients

## Interventions

- **DRUG:** SSS17
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07014631
- **Lead sponsor:** Shenyang Sunshine Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12-12
- **Final completion:** 2025-04-08
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07014631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07014631, "Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07014631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*